Hormone Replacement Therapy

Women confused about trends in hormone therapy treatments, online survey shows

Published in Medical Letter on the CDC and FDA, May 15th, 2005

In a national survey, 86% of women were unaware that custom-made hormone therapy treatments created in a compounding pharmacy are not approved by the U.S. Food and Drug Administration (FDA). The finding came from an online survey conducted by MenopauseRx.com.

Ironically, 75% of those same respondents thought FDA approval was very important when considering a hormone therapy treatment option.

Survey results also showed women are unclear about the difference between bioidentical hormones versus so-called "natural" hormones. Only 38% of women knew the terms bioidentical and natural referred to different types of treatments. Bioidentical hormone therapy...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2005-05-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry